Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,765
Closed -$218K 682
2025
Q4
$218K Sell
2,765
-282
-9% -$22.3K 0.01% 712
2025
Q3
$251K Buy
3,047
+38
+1% +$2.99K 0.01% 682
2025
Q2
$242K Buy
3,009
+60
+2% +$4.63K 0.01% 669
2025
Q1
$237K Buy
2,949
+22
+0.8% +$1.83K 0.01% 624
2024
Q4
$240K Buy
+2,927
New +$244K 0.01% 593
2024
Q3
Sell
-2,935
Closed -$206K 531
2024
Q2
$206K Buy
+2,935
New +$210K 0.01% 593
2024
Q1
Sell
-3,836
Closed -$254K 495
2023
Q4
$254K Buy
3,836
+91
+2% +$5.7K 0.02% 502
2023
Q3
$236K Buy
+3,745
New +$233K 0.02% 486
2023
Q2
Sell
-3,583
Closed -$208K 434
2023
Q1
$208K Buy
3,583
+403
+13% +$27.2K 0.02% 486
2022
Q4
$230K Buy
+3,180
New +$228K 0.02% 440
2022
Q2
Sell
-3,199
Closed -$224K 507
2022
Q1
$224K Sell
3,199
-6
-0.2% -$406 0.02% 455
2021
Q4
$200K Buy
+3,205
New +$201K 0.02% 482
2019
Q3
Sell
-5,281
Closed -$262K 427
2019
Q2
$262K Sell
5,281
-394
-7% -$18.5K 0.05% 294
2019
Q1
$241K Sell
5,675
-302
-5% -$13.4K 0.05% 297
2018
Q4
$245K Sell
5,977
-201
-3% -$8.62K 0.06% 269
2018
Q3
$288K Buy
6,178
+884
+17% +$40.4K 0.05% 302
2018
Q2
$230K Sell
5,294
-1,139
-18% -$53.1K 0.05% 320
2018
Q1
$295K Buy
6,433
+359
+6% +$17.4K 0.07% 270
2017
Q4
$307K Buy
+6,074
New +$320K 0.07% 257

Other funds holding MET

IFG Advisory's MET Position: Q1 2026 in Review

IFG Advisory sold out of MetLife (MET) in Q1 2026, closing a stake of 2,765 shares — an estimated $218K sold.

IFG Advisory first reported a position in MET in Q4 2017 and held it in 19 quarters. The position peaked at $307K in Q4 2017. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • IFG Advisory reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • IFG Advisory sold 2,765 MetLife shares in Q1 2026, an estimated $218K.
  • IFG Advisory first reported a position in MetLife in Q4 2017 and held it in 19 quarters.
  • IFG Advisory's MetLife position peaked at $307K in Q4 2017.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.